These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32753880)

  • 1.
    Gao S; Song D; Liu Y; Yan H; Chen X
    Onco Targets Ther; 2020; 13():6339-6349. PubMed ID: 32753880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
    Ding Y; Gao S; Zheng J; Chen X
    Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lan KH; Lee WP; Wang YS; Liao SX; Lan KH
    Oncotarget; 2017 Dec; 8(69):113460-113471. PubMed ID: 29371922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting the HPV16 oncogene-mediated glycolysis sensitizes human cervical carcinoma cells to 5-fluorouracil.
    Ma D; Huang Y; Song S
    Onco Targets Ther; 2019; 12():6711-6720. PubMed ID: 31695407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori CagA protein induces gastric cancer stem cell-like properties through the Akt/FOXO3a axis.
    Chen ZW; Dong ZB; Xiang HT; Chen SS; Yu WM; Liang C
    J Cell Biochem; 2024 Mar; 125(3):e30527. PubMed ID: 38332574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in
    Chen D; Li C; Zhao Y; Zhou J; Wang Q; Xie Y
    PeerJ; 2021; 9():e11203. PubMed ID: 33954041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
    Shao X; Zheng X; Ma D; Liu Y; Liu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development.
    Zhang BG; Hu L; Zang MD; Wang HX; Zhao W; Li JF; Su LP; Shao Z; Zhao X; Zhu ZG; Yan M; Liu B
    Oncotarget; 2016 Mar; 7(9):9788-800. PubMed ID: 26848521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori cytotoxin-associated gene A protein upregulates α-enolase expression via Src/MEK/ERK pathway: implication for progression of gastric cancer.
    Chen S; Duan G; Zhang R; Fan Q
    Int J Oncol; 2014 Aug; 45(2):764-70. PubMed ID: 24841372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions.
    Chen ZM; Hu J; Xu YM; He W; Meng L; Huang T; Ying SC; Jiang Z; Xu AM
    World J Gastrointest Oncol; 2021 Jul; 13(7):693-705. PubMed ID: 34322198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract of
    Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
    World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion.
    Zhang X; Li C; Chen D; He X; Zhao Y; Bao L; Wang Q; Zhou J; Xie Y
    Inflamm Res; 2022 Jan; 71(1):141-155. PubMed ID: 34854954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
    Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
    Kang DW; Hwang WC; Park MH; Ko GH; Ha WS; Kim KS; Lee YC; Choi KY; Min DS
    Oncogene; 2013 Jul; 32(30):3531-42. PubMed ID: 22890316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel effects of Helicobacter pylori CagA on key genes of gastric cancer signal transduction: a comparative transfection study.
    Vaziri F; Peerayeh SN; Alebouyeh M; Maghsoudi N; Azimzadeh P; Siadat SD; Zali MR
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25743471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway.
    Ou Y; Ren H; Zhao R; Song L; Liu Z; Xu W; Liu Y; Wang S
    Mol Carcinog; 2019 Aug; 58(8):1427-1437. PubMed ID: 31162747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA.
    Chaturvedi R; Asim M; Romero-Gallo J; Barry DP; Hoge S; de Sablet T; Delgado AG; Wroblewski LE; Piazuelo MB; Yan F; Israel DA; Casero RA; Correa P; Gobert AP; Polk DB; Peek RM; Wilson KT
    Gastroenterology; 2011 Nov; 141(5):1696-708.e1-2. PubMed ID: 21839041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.
    Kang DW; Yang ES; Noh YN; Hwang WC; Jo SY; Suh YA; Park WS; Choi KY; Min DS
    J Pathol; 2017 Apr; 241(5):614-625. PubMed ID: 28008607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.